Date: 4th September, 2026
Corporate Communication
Annual General Meeting (AGM) Details
The 38th Annual General Meeting (AGM) of SMS Pharmaceuticals Limited is scheduled to be held on Tuesday, 29th September, 2026 at 10.30 A.M. (IST). The meeting will be conducted through Video Conference (VC) / Other Audio-Visual Means (OAVM). The Notice of the AGM and the Integrated Annual Report are being sent electronically to members with registered email IDs.
Dividend Declaration
- Proposed Dividend: ₹0.40 per equity share of face value ₹1/- each.
- Record date/Cut-off date for eligibility of Dividend: 22nd September, 2026.
- Date for payment of Dividend: Within 30 days from the date of declaration of dividend.
Shareholder Information
Shareholders holding shares in physical form whose folios do not have updated PAN and KYC details are reminded that they will only be eligible to receive dividends through electronic mode. They are requested to submit the relevant ISR Forms to update these details before the record date of 22nd September, 2026. Demat holders should contact their Depository Participants for KYC assistance, while physical folio holders should contact the RTA at info@aarthiconsultants.com.
Accessing the Annual Report
The Integrated Annual Report for FY 2025-26 can be accessed via:
- Exact Path: Home Page > Click on "Investors" > Select "Annual Report" > Select "Annual Reports 2026"
- Direct Weblink: https://smspharma.com/wp-content/uploads/2026/09/2026.pdf
- A QR code for the Annual Report is also provided in the original document.
Other Sections
Financial Results: Not Specified.
KMP / Board / Auditor Changes: Not Specified.
Board Meeting Outcomes: Not Specified.
Auditor’s Report: Not Specified.
Disinvestment / Strategic Actions: Not Specified.
Media Release / Investor Communication: Not Specified.